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ABSTRACT 
BACKGROUND: 
 
 It has been suggested that chronic infections may predispose to 
cardiovascular disease.  The relationship between periodontal disease and 
cardiovascular disease has been a subject of increasing research in recent years.  
The isolation and identification of periodontal bacteria from atheromatous 
plaque can contribute to our knowledge of this vascular disease. 
 
AIM: 
 The aim of this study was to isolate and identify periodontal pathogens 
from the sub gingival plaque of different patients and to compare them with the 
microorganisms detected in the atheromatous plaque obtained from the same 
patients. 
 
METHODS: 
 
 The study was performed on twenty five individuals with 
atherosclerosis. Atheromatous Plaques was collected from the patients during 
endarterectomy and the subgingival plaque was collected from the same 
patients with clinical attachment level ≥ 4mm. Total DNA isolation was done, 
the presence of 16S rDNA for P.Gingivalis,T.Denticola, T.Forsythia and A 
actinomycetem comitans was determined using PCR technique.  The products 
were sequenced and they were compared with type strains from Gen Bank by 
blast to confirm their sequence homology.  McNemar’s Test was used for 
statistical analysis. 
RESULTS: 
The DNA of atleast one of the target bacteria was detected in 96% of the 
sub gingival Plaque samples.  The prevalence of P.gingivalis, T. Denticola, and 
T. Forsythia was 92%, 80% and 96% respectively. The prevalence of 
P.Gingivalis, T.Forsythia, and T.Denticola in atheromatous plaque samples 
was 64%, 56% and 76% respectively. The DNA of periodontal bacteria except 
A.actinomycetemcomitans was detected in both sub gingival samples and 
atheromatous samples. In 16 of 25 cases, P.gingivalis was present in both sub 
gingival samples and atheromatous plaque samples at P value of 0.008. In 19 
cases, T.denticola was present in both sub gingival samples and atheromatous 
plaque samples at P value of 0.031 and T.forsythia were present in both 
subgingival and atheromatous plaque samples in 14 cases at P value of 0.016.  
 
CONCLUSION: 
 
The presence of P.Gingivalis, T. Denticola, T. forsythia in both 
atheromatous plaques and the subgingival plaque of an individual could 
indicate a role for periodontal pathogenic bacteria in atherosclerosis disease 
process.   
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INTRODUCTION 
Several hundred different species of bacteria inhabit the oral cavity. 
Among these periodontal diseases associated bacteria adhere to and colonize 
the periodontal pocket. 
Periodontitis is a bacterially induced, localized, chronic inflammatory 
disease, destroys connective tissue and bone that support the teeth. 
Periodontitis begins with a microbial infection, followed by a host mediated 
destruction of soft tissue caused by hyper activated or primed leukocytes and 
the generation of cytokines, eicosanoids and matrix metalloproteinases that 
causes clinically significant connective tissue and bone destruction (Kornman 
KS et al 1997) 51. 
Bacterial accumulation on the teeth  are essential to the initiation and 
progression of periodontitis .Cells that mediate immunity, such as neutrophils, 
play a major role in  the host response against invading periodontopathic 
organisms. When bacterial biofilms on the teeth are not disrupted on a regular 
basis, ecologic changes lead to the emergence of a small set of gram negative  
anaerobic bacterial species, including  Porphyromonas gingivalis, Treponema 
denticola and Tannerella forsythia, which are consistently associated with 
periodontitis. These bacteria activate many host immunoinflammatory 
processes and disrupt host mechanism involved in bacterial clearance and are 
considered pathogens in periodontitis. 
Annexure 
 
2 
 
Chronic infection can be one of the contributing factors involved in 
atherosclerosis (Ross. R 1999)75. It has been suggested that periodontal 
pathogens can penetrate gingival tissues and enter the blood stream (Lamont 
RJ et al 199553, Fives – Taylor.P.D. et al 199529) and may also induce a 
continuous benign bacteraemia (Sconyers JR et al 197379) that can allow 
species associated with periodontal diseases to migrate to atheromatous 
plaques. 
This study was undertaken to ascertain the presence of DNA of 
periodontal bacteria, Tannerella forsythia, Porphyromonos gingivalis, 
Treponema denticola,   Aggregatibacter actinomycetemcomitans, in coronary 
atheromatous plaque and to compare them with periodontal bacteria from the 
subgingival plaque samples obtained from the same patients. 
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AIM AND OBJECTIVES 
 
The aim of this study was to isolate and identify periodontal pathogens from 
the subgingival plaque of different patients and to compare them with the 
microorganisms detected in the atheromatous plaque.  
For the purpose, following objectives were undertaken. 
1. 16S rDNA screening of Porphyromonas gingivalis, Treponema denticola, 
Aggregatibacter actinomycetemcomitans, Tannerella forsythia, in         
subgingival plaque samples of atherosclerotic patients by polymerase chain 
reaction 
 
2. 16S rDNA screening of Porphyromonas gingivalis, Treponema denticola, 
Aggregatibacter actinomycetemcomitans, Tannerella forsythia,in 
atheromatous plaque samples of the same patients by polymerase chain 
reaction 
 
3. To find out the statistical significance of organisms detected in subgingival    
plaque and atheromatous plaque 
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REVIEW OF LITERATURE 
PERIODONTITIS AND ITS BACTERIAL ETIOLOGY  
 
Breasted J H in 193012 stated, periodontal disease was the most common of 
all the diseases found in the embalmed bodies of ancient Egyptians. Armitage GC in 
19994 reported that, numerous forms of periodontal disease are found in adult 
populations, characterized by different rates of progression and different responses to 
treatment.  
According to analysis of NHANES III data47 for adults 30yrs and older, the 
prevalence of periodontal attachment loss, ranging from a high of 99% for a threshold 
greater than 1mm to a low of 7% for a threshold greater than 7mm. At a threshold of 
greater than 3mm, the prevalence of attachment loss in at least 1 site in the mouth was 
53%. The prevalence of attachment loss increased steadily with age from a low of 
35.5% for the 30-39 year old groups to a high of 39.2% for the 80-90 year old groups. 
On average per person 19.6 of teeth had attachment loss greater than 3mm. Among 
people with at least one side of attachment loss greater than 3mm on an average 
36.6% of the teeth per person was affected. 
German dentist Adolph Witzel (1847-190634) was the first individual to 
identify bacteria as the cause of periodontal disease.  
Willoughby D.Miller (1853-190734) in his book “The Microorganisms of the 
human Mouth” published in 1890, described the features of periodontal diseases and 
he believed that the disease was not caused by a specific bacterium but by a complex 
array of various bacteria. This constitutes what was later known as the non specific 
plaque hypothesis.  
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In mid 1960s the classic studies of Loe55 et al and Theilade et al 
convincingly demonstrated that plaque accumulation directly preceded and initiated 
gingivitis and led to the eventual destruction of periodontal tissues. 
Tanner et al in 197985 demonstrated that the microbial composition of 
subgingival plaque taken from diseases sites differed substantially from the samples 
taken from healthy sites in chronic periodontitis. 
Haffajee & Socransky in 199436 stated, that the periodontal diseases appear 
to be caused by a relatively definite group of periodontal pathogens acting alone or in 
combination and it is well established that periodontal diseases represent mixed 
infections of periodontal tissues caused primarily by anaerobic gram negative 
bacteria. 
In 1998 Socransky et al83 examined over 13,000 subgingival plaque samples 
from 185 adult subjects, to demonstrate the presence of specific microbial group 
within the dental plaque. Six closely associated groups within dental plaque were 
recognized in which T.forsythia, P.gingivalis & T.denticola recognized as red 
complex. 
The World Workshop in Periodontology (consensus report 1996)47 
designated A.actinomycetemcomitans, P.gingivalis and T.forsythia as periodontal 
pathogens. 
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A.actinomycetemcomitans and Periodontitis 
Newman et al in 197665 reported that, A.actinomycetemcomitans was first 
recognized as possible pathogen by its increased frequency of detection and higher 
numbers in lesions. 
Baehni et al in19795 found that, A.actinomycetemcomitans produces a 
number of potentially damaging metabolites including a leukotoxin. 
Zambon J J et al in 198393 stated,  A.actinomycetemcomitans Serotype a  was 
more commonly detected in samples from chronic periodontitis subjects. 
Rodenburg J P et al in 199074 found that, A.actinomycetemcomitans has also 
been implicated in adult forms of destructive periodontal disease, but its role is less 
clear. The species has been isolated from chronic periodontitis lesions, but less 
frequently and in lower numbers than lesion in LAP subjects. 
Vanwinkelhoff et al in 199291 treated 50 adults with severe generalized 
periodontitis and 40 subjects with refractory periodontitis who were cultured positive 
for A.actinomycetemcomitans  using mechanical debridement and systemically 
administered amoxicillin and metronidazole, only one of subjects  was culture 
positive for A.actinomycetemcomitans  3-9 months post therapy. 
Kolenbrander et al in 200050 stated that, A.actinomycetemcomitans  may 
attach to other colonizing bacterial species by co aggregation  
Rudney et al in 200176 found that, at some point these organisms may move 
from the supra gingival to subgingival environment from this vantage point they may 
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then attach to and invade the epithelial lining of periodontal pocket and possibly 
penetrate the underlining connective tissues. 
P.gingivalis and periodontitis 
P.gingivalis is a second consensus periodontal pathogen that continues to be 
intensely investigated organisms of this group form brown to black colonies on blood 
agar plates and were initially grouped into a single species,B.meleninogenicus 
(BacteriumMelaninogenicum). Burdon et al in 192816 found that this black 
pigmented bacteriodes have a long history of association with periodontal diseases. 
Dzink et al in 198825 found that, Porphyomonas gingivalis has been found in 
higher numbers on or in epithelial cells recovered from the periodontal pocket then in 
associated plaque. 
Bragd et al in 198711 reported that, P.gingivalis has been shown to be reduced 
in successfully treated sites but was commonly encountered in sites that exhibited 
reoccurrence of diseases or persistence of deep periodontal pockets post therapy. 
Holt et al in 198844 demonstrated that P.gingivalis suppressed by systemic 
administration of rifampin but the re introduction of P.gingivalis resulted in initiation 
and progress of the lesion. 
Beck et al in 19909 stated that P.gingivalis has been associated with an 
increased risk of periodontal disease severity and progression. 
Haffajee and socransky in 199436 observed that, studies initiated in the late 
1970s and extending to the present have strengthened the association of P.gingivalis 
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with disease and demonstrated that the species is uncommon and in low numbers in 
health or gingivitis but more frequently detected in destructive forms of disease. 
Tannerella forsythia and Peridontitis 
 Tannerella forsythia was the third consensus periodontal pathogen, and it was 
first described in 1979 as a “fusiform” Bacteroides. Tanner et al in 197985   
Lai et al in 198752 reported findings using fluorescent labeled polyclonal 
antisera and demonstrated that T.forsythia was much higher in subgingival than supra 
gingival plaque samples. 
Initially T.forsythia was thought to be a relatively uncommon subgingival 
species. However the studies of G Mur R et al in 198930 using mono clonal 
antibodies to enumerate the species directly in plaque samples suggested that the 
species was more common than the previously found in culture studies and its levels 
were strongly related in increased pocket depth. 
Haffajee et al in 199737 observed that, T.forsythia has been shown to be 
decreased in frequency of detection and counts after successful periodontal therapy 
including scaling and root planing. 
Vanwinkelhoff et al in 200290 found that, T.forsythia was in much higher 
counts, proportions and prevalence in subjects with various forms of periodontitis 
than in periodontally healthy subjects. 
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Hamlet et al in 200438 showed that, there was a greater risk of periodontal 
attachment loss in adolescents who were colonized by T.forsythia than adolescents in 
whom the species was not detected. 
 
T.denticola and periodontitis 
Keyes&Rams in 198348observed that, the Spirochetes have been considered 
as possible periodontal pathogens since the late 1800’s and in the 1980s enjoyed the 
resurgence of interest for use as possible diagnostic indicators of disease activity and 
for therapeutic efficacy. 
Simonson L.G et al in 198881 showed that , T.denticola was found to be more 
common in periodontally diseased than healthy sites, more common in subgingival 
than supra gingival plaque. 
Simonson L.G et al in 199282 found that, T.denticola was shown to decrease 
in successfully treated periodontal sites, but not change or increase in non responding 
sites. 
Kigure et al in 199549 observed that, T. denticola have been shown to be at 
the fore front of periodontal lesions as demonstrated in sections of undisturbed 
subgingival plaque using immuno histochemical localization.  
Riviere et al in 199771 showed their presence in periodontally healthy sites 
was related to an increased risk of development of periodontitis. The reduction is so 
consistent that it has been used in some studies as a measure of compliance in 
determining whether subjects used the prescribed antibiotics. 
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PERIODONTITIS AND ATHEROSCLEROSIS 
The concept of systemic diseases originating in dental and oral infections had 
been mentioned in Assyrian Clay tablets by Hippocrates(460-370BC)17. 
In the 19th Century, Benjamin Rush in 181817 and Leonard Koecker in 
182817 recognized the role of oral sepsis in rheumatic and other diseases. 
Later in the 19th Century W.D.Miller in 189117 also mentioned oral infections 
as the cause of many diseases. 
William Hunter (1861-1937)45 in 1900, a British physician indicated 
dentistry as being the cause of oral sepsis which in turn caused rheumatic and other 
chronic diseases.  
A number of studies have reported associations between periodontitis and 
heart disease. Probably the earliest study was published in 1963 by Mackenzie and 
Millerd)17. The study was conducted onto individuals with suspected diabetes and 54 
atherosclerotic individuals. The only group to exhibit more bone loss than it control 
was the atherosclerotic non diabetic group in which 63% had more bone loss than 
controls. 
Silver et al in 197780 stated frequent bacteraemia occur as a result of daily 
activities such as tooth brushing or chewing in periodontitis patients. 
Nery E.B. et al in 198764 in their article titled “Prevalence of Medical 
problem in periodontal patients obtained from three different populations” reported 
that cardiovascular disease was the most prevalent problem in all groups. 
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Mattila and colleagues in198959 were the first to show a statistical 
association between dental infections and advanced atherosclerosis. 
 
In 1993, Destefeno and colleagues23 examined the relationship between 
periodontal disease and CHD and observed an approximately 25% increased risk for 
CHD (RR 1.25, CI 1.06 – 1.48)individuals with periodontal disease after controlling 
for race, education, systolic blood pressure, cholesterol, alcohol consumption, Body 
Mass Index (BMI), exercise and poverty index. This was the first large scale study 
with a follow up period of 14 years and adjusting for confounding factors. 
Genco et al in 199732 studied the relationship between tooth loss and alveolar 
bone loss and CVD as confirmed by Electro Cardio Gram (ECG). They observed a 
high relative risk of 2.69 for CVD with alveolar bone loss. 
Noack et al in 200166 observed statistically significant increase in CRP levels 
in 109 subjects with moderate to severe periodontitis when compared with 65 healthy 
controls. After adjustments for factors known to be associated with elevated CRP, 
including age, smoking, BMI, triglycerides and cholesterol subjects with high levels 
of Mean clinical attachment loss had significantly higher CRP levels (4.06 ±     
5.55mg/L) than did controls (1.70   ±  1.91 mg/L, P=0.011) 
Bhulin et al in 200313 reported that the presence of periodontal pathogens-
including Porphyromonasgingivalis, Prevotella intermedia and T.forsythia- from 
subgingival plaque samples was positively associated with elevated CRP levels 
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(p=0.029).CRP levels were also reported to be higher in 50 CVD patients with severe 
periodontitis ≥ 4mmPD. 
Chiu B in 199918 isolated P.gingivalis and S.sanguis in the arterial plaque 
from a carotid endarterectomy specimen that suggested possible invasion of the 
periodontopathogens in the carotid atheroma.        
Dorn and colleagues in 199924 reported that P.gingivalis appeared to invade 
coronary artery endothelial cells and increase the degradation of endothelial cell 
proteins. 
Haraszthy and colleagues in 200039 using specific oligonucleotide primers in 
polymerase chain reaction (PCR) assays , detected microbial ribosomal RNA in 
atheromatous plaque .They were C.pneumoniae ,as well as dental pathogen and Cyto 
Megalo Virus .30% were positive for T.forsythia, 26% for P.gingivalis and 18% for 
A.actinomycetem comitans and 14% for P intermedia.  
Choi and colleagues in 200219 isolated P.gingivalis heat shock protein ,T –
specific T-cells in atherosclerosis plaque from subjects with severe atherosclerosis. 
Taylor- Robinson and colleagues in 200287 isolated several infectious agents 
by DNA identification methods from all major arteries affected by atherosclerosis. 
Nearly 40% of specimens were positive for Chlamydia pneumoniae and 35.4% were 
positive for mixture of Chlamydia and A.actinomycetemcomitans and 
P.intermedia.These findings suggest a possible invasion of the major arteries by oro-
dental pathogens. 
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Padilla C et al in 200667 stated that, the presence of A .actinomycetem 
comitans in atheromatous plaques and the periodontal pockets of the same patients 
could indicate a role for periodontal pathogenic bacteria in the atherosclerosis disease 
process.  
Pucar A et al in 200770, stated the absence of putative pathogenic bacteria in 
internal mammary arteries, which are known to be affected rarely by atherosclerotic 
changes, and their presence in a high percentage of atherosclerotic coronary arteries 
support the concept that periodontal organisms are associated with the development 
and progression of atherosclerosis 
Almetti M et al in 20071 observed that, bacterial DNA was detected in 31 out 
of 33 endarterectomy specimens. However, none of the samples tested positive for 
DNA from periodontal pathogens. The presence of periodontal bacteria in 
atheromatous plaques was not confirmed by this investigation, thus no correlation 
could be drawn between periodontitis bacteria and microorganisms involved in the 
atherosclerotic lesions.  
Mustapha T Z et al in 200763 reported that, periodontal disease with elevated 
bacterial exposure is associated with CHD events and early atherogenesis, suggesting 
that level of systemic bacterial exposure from periodontitis is the biologically 
pertinent exposure with regard to atherosclerosis risk.   
Rufail M L et al in 200777 found that, the periodontal infection is associated 
with elevated plasma levels of atherogenic lipoprotein species. This association may 
account for the increased risk of periodontitis patients for cardiovascular disease. 
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Elkam R et al in 200826 found that, the presence of periodontal pathogens in 
atherosclerotic plaques and in apparently healthy vessels appeared to reflect a higher 
level of bacteraemia rather than infection of endothelial cells.  
Monterio A M et al in 200961 studied the cardiovascular disease parameters 
in periodontitis patients. The level of triglycerides and high density lipoprotein in 
periodontitis patients were significantly higher and lower, respectively compared to 
controls. total cholesterol, low- density lipoprotein and lipid peroxide level were the 
same  in both groups. Interleukin IL -6 and -8, antibodies against  oxidized low –
density lipoprotein, and leukocyte and neutrophils count were significantly higher in 
periodontitis patients. The results confirmed and further strengthened the suggested 
association between coronary artery disease and periodontitis.  
Buhlin K in 200914 in his study showed increased levels of antibodies against 
Hsp 65 and 70 and decreased level of antibodies against Hsp 60 periodontitis was 
associated with increased levels of CRP, glucose, fibrinogen and IL -18 and with 
decreased levels of IL-4.  
Buhlin K in 200915 in his study investigated the effect of mechanical infection 
control for periodontitis on the prevalence of well established risk factors for 
atherosclerosis. 12 months after periodontal treatment HDL-concentration were 
increased where as LDL-concentration decreased haptoglobin concentration were also 
lowered and IL18  and INF- γ level lowered but no effect on plasma levels of IgA, 
IgG1 and IgG2 antibodies against heatshock proteins. This study indicates that 
standard treatment for periodontal disease induces systemic changes in several 
biochemical markers that reflect the risk of atherosclerosis.  
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Tonetti MS in 200989 stated that, the Periodontitis has effects that go beyond 
the oral cavity and its treatment and prevention may contribute to the prevention of 
atherosclerosis.  
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MATERIALS AND METHOD 
SUBJECT SELECTION 
25 subjects who underwent endarterectomy were selected and screened, out of 
the patients who hospitalized at the coronary care unit, Frontier life line Hospital, 
DR.K.M.Cherian Heart Foundation,Chennai – 600101. The subjects were examined 
periodontally, subgingival plaque samples, and their respective carotid atheromatous 
plaques were collected. 
INCLUSION CRITERIA 
• Patients underwent endarterectomy 
• Either sex 
• Age 40-70 yrs 
• At least 14 teeth should be present 
• At least 3 teeth with CAL≥ 4 mm 
EXCLUSION CRITERIA 
• Edentulous patients 
• Critically ill cardiac patients 
• All third molar teeth are excluded 
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STUDY PROTOCOL 
• Medical history and informed consent 
• Periodontal examination using clinical parameters namely plaque index, 
probing pocket depth and clinical attachment level. 
• Collection of subgingival plaque sample 
• Collection of atheromatous  plaque sample following endarterectomy 
• DNA isolation 
• Polymerase chain reaction for amplification of 16S rDNA Porphyromonas 
gingivalis, Treponema denticola, Aggregatibacter 
actinomycetemcomitans,Tannerella forsythia.  
• Gel electrophoresis 
• Sequencing of the amplified product 
• Statistical analysis 
Following the approval from Institutional Ethical Committee, subjects were 
selected, informed consent was obtained from all the subjects selected for the study 
after explaining the study procedure. Prior to the examination a thorough medical and 
dental history was taken. 
Intra-oral examination was done using mouth mirror and William’s 
periodontal probe. Periodontal evaluation was done by measuring the plaque index, 
probing pocket depth (PPD) and clinical attachment level (CAL). Atheromatous 
plaque sample of the corresponding patients were received from the histopathology 
department.  
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CLINICAL PARAMETERS 
Plaque Index (Silness & Loe’196417)  
Teeth examined - All teeth 
Surfaces examined - Distofacial, facial, mesiofacial, lingual. 
Criteria for Scoring 
Score 0: No Plaque 
Score 1: Film of plaque at the marginal area recognized by running of a probe 
Score 2: Moderate accumulation that can be seen by naked eye 
Score 3: Abundance of soft deposits 
Total Score 
Plaque index per teeth =        
                                                      4 
         
    Total PI per tooth 
Plaque index per individual =  
                                                 Total number of teeth examined 
 
Interpretation 
0 - Excellent 
0.1-0.9 - Good 
1.0-1.9 - Fair 
2.0-3.0 – Poor 
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PROBING POCKET DEPTH (PPD) (GRANT 196535)  
Probing pocket depth is measured from the gingival margin to the base of the 
pocket using William’s periodontal probe. The probe is passed under the gingiva 
along the circumference of the tooth. Three measurements are made on the buccal 
aspect and three on the lingual aspect of each tooth-total of six sites per tooth. 
                                      
CLINICAL ATTACHMENT LEVEL (CAL) [Carranza AF17] 
Clinical attachment level is measured from the cementoenamel junction to the 
base of the pocket using William’s periodontal probe. When the gingival margin is 
located on the anatomic crown, the level of the attachment is determined by 
subtracting from the probing pocket depth, the distance from the gingival margin to 
the cementoenamel junction. 
If both are the same, the loss of attachment is zero. When the gingival margin 
coincides with the cementoenamel junction, the loss of attachment equals the probing 
pocket depth. 
When the gingival margin is located apical to the cementoenamel junction, the 
loss of attachment is greater than the probing pocket depth and therefore the distance 
between the cementoenamel junction and the gingival margin should be added to the 
probing pocket depth. 
Three measurements are made on the buccal aspect and three on the lingual 
aspect of each tooth-total of six sites per tooth. 
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COLLECTION OF SUBGINGIVAL PLAQUE SAMPLE 
For each patient, the deepest pocket were selected and isolated for the sample 
collection and subgingival plaque samples were taken from the bottom of periodontal 
pockets from the deepest site with a sterile Gracey curette after removal of the supra 
gingival plaque. 
The plaque is dislodged from the curette by gentle rotation in a labeled vial 
containing 500 μl of sterile phosphate buffered saline. (PBS) (pH 7.8) and kept in a 
thermos ice pack, the samples were transferred to the laboratory (IBMS, Tharamani, 
Chennai) stored at -200 C till the time of Microbiological analysis. 
DNA EXTRACTION: 
The samples obtained were centrifuged and supernatant was discarded. To the 
residual 200 μl of lysis buffer was added, vortexed and it was boiled for 10 minutes 
and then micro centrifuged at 10,000 rpm for 3 minutes.  The resultant supernatant 
was stored at -20 ºC till the assay. And 10 μl of the supernatant was directly used as 
template in PCR. 
COLLECTION OF ATHEROMATOUS PLAQUE SAMPLE 
Atheromatous plaque sample collected in a labelled vial containing 500 μl of 
sterile phosphate buffered saline (PBS) (pH 7.8) during endarterectomy was received 
from histopathology department. And kept in a thermos ice pack, the samples were 
transferred to the laboratory (IBMS, Tharamani, Chennai) stored at -200 C till the time 
of Microbiological analysis. 
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DNA EXTRACTION: 
The atheromatous Plaque were dissociated with a spatula and then 
homogenized thoroughly with a tube pestle. The samples obtained were centrifuged 
and supernatant was discarded. To the residual 200 μl of lysis buffer was added, 
vortexed and it was boiled for 10 minutes and then micro centrifuged at 10,000 rpm 
for 3 minutes.  The resultant supernatant was stored at -20 ºC till the assay. And 10 μl 
of the supernatant was directly used as template in PCR. 
COMPOSITION OF LYSIS BUFFER 
• 10 mM Tris-HCl 
• 1.0mM EDTA 
• 1.0 % Triton X-100 (pH 7.8) 
POLYMERASE CHAIN REACTION 
The PCR involves the enzymatic amplification of DNA in vitro. This method 
is capable of increasing the amount of the target DNA sequence in a sample by 
synthesizing many copies of the DNA segment. 
PCR is carried out in discrete cycles and each cycle of amplification can, (if 
100 % efficient) doubles the amount of target DNA. The target DNA is exponentially 
amplified such that after n cycles, there is 2n times as much target DNA as was 
present initially (Erlich HA et al 199128). 
The basic technique of PCR includes repeated cycles of amplifying selected 
nucleic acid sequences (Mullis KB et al 198762). 
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Each cycle consists of three steps 
1.  A DNA denaturation step, in which the double strands of the target DNA are 
separated 
2.  A primer annealing step, performed at a lower temperature, in which primers 
anneal to their complementary target sequences 
3.  An extension reaction step, in which DNA polymerase extends the sequences 
between the primers. 
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PRIMERS UTILIZED IN THIS STUDY 
 
 
 
  
SNO PRIMER NAME PRIMER SEQUENCE 
FRAGMENT 
SIZE 
1 
 
 
 
16S rDNA forward 
A.actinomycetemcomita
ns 
 
16S rDNA  reverse 
A.actinomycetemcomita
ns 
5'-AAA CCC ATC TCT GAG 
TTC TTC TTC-3' 
 
 
5'-ATG CCA ACT TGA CGT 
TAA AT-3' 
557bp 
2 
 
 
 
16S rDNA forward 
P.gingivalis 
16S rDNA reverse 
P.gingivalis 
5'-AGG CAG CTT GCC ATA 
CTG CG-3' 
 
5'-ACT GTT AGC AAC TAC 
CGA TGT -3' 
 
404bp 
3 
 
16S rDNA forward 
T.denticola 
16S rDNA reverse   T 
.denticola 
5'-TAA TAC CGA ATC TGC 
TCA TTT ACA T-3' 
5'-TCA AAG AAG CAT TCC 
CTC TTC TTC TTA -3' 
316bp 
4 16S rDNA forward 
T.forsythia 
16S rDNA reverse 
T.forsythia 
5'-GCG TAT GTA ACC TGC 
CCG CA -3' 
5'-TGC TTC AGT GTC AGT 
TAT ACC T-3' 
641bp 
 
Ashimoto  et al oral microbiology and immunology 1996:11:266-273(2)  
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PREPARATION OF WORKING STOCK 
The primers were diluted from the stock as per the required concentrations. 
For one reaction, the PCR reaction mixture contains the following reagents. 
 
  REAGENT Volume in μl 
10 X PCR Buffer 5.0 
dNTP 0.25Mm (medox) 1.0 
Forward primer →25 picomol (sigma) 1.0 
Reverse primer →25 picomol (sigma) 1.0 
Mgcl2 -2.5mmol                                                1.0 
Taq polymerase (banglore genei)(2 units) 0.5 
Template 10.0 
Sterile milipore water 30.5 
Total reaction volume 50 
  
  
Annexure 
 
25 
 
PCR THERMOCYCLING PROGRAMME 
 
90 μl of the PCR reaction mix was pipetted into micro centrifuge tubes.10 μl 
of the template DNA was added and mixed thoroughly. The micro centrifuge tubes 
were placed in a thermocycler (AB biosystem) and cycling conditions were set. 
 
THERMAL CYCLING CONDITIONS 
1.  Initial denaturation step at 94oC for 5 minutes followed by 
2.  35 cycles of 
• Denaturation at 94oC for 1 minute 
• Primer Annealing at 50oC for 1 minute 
• Extension at 72oC for 1.5 minutes and 
 
3.  Final extension step at 72oC for 7 minutes 
 
GEL ELECTROPHORESIS FOR DETECTION OF AMPLICON 
The PCR product was detected by 1.5% Agarose gel electrophoresis. 
 
REAGENTS REQUIRED 
1.  Preparation of TAE Buffer (1x) 
• 490 ml of double distilled water  
• 10 ml of 50 x TAE Buffer  
 
2.  Ethidium bromide 
• Ethidium bromide - 10 mg 
• Distilled water - 1 ml 
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PROCEDURE 
PREPARATION OF 1.5% AGAROSE GEL 
• 1.5 gram of agarose weighed and transferred into 250 ml conical flask. 
 
• 100 ml of 1x TAE buffer was added to it, mixed gently and boiled in a microwave 
oven. 
 
• The appropriate sized gel tray and comb was washed. Cello tape was fixed on 
both sides of the tray. The comb was placed on the gel tray without touching the 
bottom and left on an even surface. 
 
• Agarose was cooled down, 0.5 μl of ethidium bromide was added and mixed well. 
It was poured on the gel tray and allowed to polymerize. 
 
PREPARATION OF SAMPLE AND LOADING 
 
• The cello tape was removed from the gel tray and the tray placed in the 
electrophoresis tank. 
 
• 1x TAE buffer was poured into the tank until the gel gets immersed. 
 
• The comb was carefully removed from the gel tray. 
 
• 10 μl of PCR product was mixed with 10 μl of 2x gel loading buffer and loaded 
into the wells 
• The electrodes were connected. 
• The power was switched ON and set at 100 V. 
• After the completion of the electrophoresis, gel was taken to the transilluminator 
and observed under UV-light. (Biorad gel documentation) 
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INTERPRETATION: 
100 bp DNA ladder (MEDOX) was used as a size marker and sterile milli 
pore water was used as blank control. 
 
SEQUENCE OF PCR PRODUCT 
 
The PCR product of 404 bp of 16S rDNA of porphyromonas gingivalis, 557 
bp of 16S rDNA of Aggregatibacter actinomycetemcomitans, 641 bp of 16S rDNA of 
Tannerella forsythia, 316bp of 16S rDNA of Treponema denticola positive samples 
were given to MWG – BIOTECH, GERMANY for sequencing the PCR products by 
automated DNA sequencer. 
 
The data was collected and statistically analyzed. 
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ARMAMENTARIUM 
 
CLINICAL EXAMINATION AND SAMPLE COLLECTION 
• Mouth Mirror 
• William's periodontal probe 
• Tweezer 
• Face Mask 
• Head cap 
• Surgical gloves 
• Cotton rolls 
• Sterile Gracey curettes 
• Storage vials with phosphate buffered saline(500μl) 
• Thermos box with gel pack 
 
DNA ISOLATION AND PURIFICATION 
• Eppendorf tubes 
• -20oC freezer 
• Micro centrifuge 
• Water bath 
• Micropipette 
• Micro pipette tips 
 
POLYMERASE CHAIN REACTION 
• PCR tubes 
• Micropipette 
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• Micro centrifuge 
• PCR thermal cycler 
• Eppendorf tube 
• Primers 
• Sterile Millipore water 
 
AGAROSE GEL ELECTROPHORESIS 
• Gel tray 
• Gel comb 
• Cello tape 
• Agarose 
• 10x TAE buffer 
• Ethidium bromide 
• Electronic weighing balance 
• Electrophoresis tank with power supply 
• UV trans illuminator 
• Microwave oven 
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STATISTICAL ANALYSIS 
Proportions of different organisms were estimated from the subgingival 
samples and atheromatous plaque samples. 
 McNemar’s Test (1 tailed) was used to calculate the overall p value.  
McNemar’s Test was used to compare the positive rates of P.gingivalis,  
T .denticola, T.forsythia in samples from both subgingival and atheromatous plaque. 
 
STATCALC procedure available in SPSS version 13 was used for all 
statistical analysis. 
In the present study, < 0.05 was considered as the level of significance.  
McNemar’s Test 
The formula used is  
)/(])1[( 22 cbcb +−−=χ  
where b and c are the discordant cell frequencies in the 2x2 matrix. 
2χ  follows a chi-square distribution with one degree of freedom. 
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Photograph No.1  Armamentarium for Clinical Examination and sample 
collection 
 
   
 
 
 
 
 
 
 
Photograph No.2 Chronic Periodontitis 
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Photograph No.3  examination of Sample Site 
 
 
 
 
 
 
 
 
 
Photograph No.4  Insertion of Curette 
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Photograph No.5  Sub Ginvial Plaque Sample 
 
 
 
 
 
 
 
 
Photograph No.6 Atheromatous Plaque Samples 
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Photograph No.7  Sample Transport 
 
 
 
 
 
 
 
 
Photograph No.8  Water Bath – Front View 
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Photograph No.9  Water Bath – Inner Aspect 
 
 
 
 
 
 
 
 
Photograph No.10  Micro Centrifuge 
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Photograph No.11  Reagents for PCR 
 
 
 
 
 
 
 
 
 
 
 
Photograph No.12  Armamentarium for PCR 
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Photograph No.13  Thermal Cycler 
 
 
 
 
 
 
 
 
 
Photograph No.14  Armamentarium for Gel Electrophoresis 
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Photograph No.15  Gel Electrophoretic Apparatus 
 
 
 
 
 
 
 
 
 
 
Photograph No.16  UVBiorad Gel Documentation System 
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RESULTS 
Twenty five patients who underwent endarterectomy were selected and 
screened at the coronary care unit, Frontier Lifeline Hospital, DR.K.M.Cherian Heart 
Foundation,Chennai – 600101. The subjects were examined periodontally, and 
subgingival plaque samples were collected from the deepest pocket and their 
atheromatous plaque samples were obtained from histopathology department of 
Frontier Lifeline Hospital. 
The clinical parameters used were probing pocket depth, clinical attachment 
loss, CPK, CPK-MB and LDH. 
The subgingival plaque samples and atheromatous plaque samples were 
examined with PCR technique using specific primers for periodontal bacteria. DNA 
sequences of the amplified products of Tannerella forsythia, Treponema denticola, 
and porphyromonas gingivalis were compared with type strains sequences from the 
GenBank by blast to confirm their sequence homology. 
Table 1 summarises the characteristics of cases included in the study, such as 
number of patients, age, gender, probing pocket depth, clinical attachment loss, and 
the site of subgingival samples collection. 
Table 2 summarises the characteristics of cases included in the study, such as 
number of patients, age, gender, CPK, CPK-MB, LDH and the site of atheromatous 
plaques samples collection. 
Table 3 and Figure 1 shows the prevalence of P.gingivalis microorganisms in 
subgingival plaque samples and atheromatous plaque samples. 
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Table 4 and Figure 2 shows the prevalence of T.forsythia microorganisms in 
subgingival plaque samples and atheromatous plaque samples. 
Table 5 and Figure 3 shows the prevalence of T.denticola microorganisms in 
subgingival plaque samples and atheromatous plaque samples. 
Table 6 and Figure 4 shows the prevalence of A.actinomycetemcomitans 
microorganisms in subgingival plaque samples and atheromatous plaque samples. 
Table 7 shows the comparative  prevalence of P.gingivalis microorganisms in 
both subgingival  and atheromatous plaque samples. 
Table 8 shows the comparative prevalence of T.forsythia microorganisms at 
subgingival plaque samples and atheromatous plaque samples. 
Table 9 shows the comparative prevalence of T.denticola microorganisms at 
subgingival plaque samples and atheromatous plaque samples. 
The DNA of atleast one of the target bacteria was detected in 96% of the 
subgingival sample. The prevalence of P.gingivalis, T.denticola,T.forsythia was 92% 
,80%, and 96% respectively. The sequence of periodontal bacterial DNA in the 
atheromatous plaques could be ascertained by DNA sequencing and they were 
compared with type strains sequences from the Gen Bank by blast to confirm their 
sequence homology. The prevalence of P.gingivalis, T.forsythia, T.denticola was 
64%, 56% and 76% respectively. The DNA of periodontal bacteria except 
A.actinomycetemcomitans was detected in both subgingival samples and 
atheromatous samples. 
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In 16 of 25 cases, P.gingivalis was present in both subgingival samples and 
atheromatous plaque samples at P value 0.008. In 19 cases, T.denticola was present in 
both subgingival samples and atheromatous plaque samples at P value 0.031 and 
T.forsythia were present in both subgingival and atheromatous plaque samples in 14 
cases at P value 0.016.  
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Table 7  
THE COMPARATIVE PREVALENCE OF P.gingivalis MICROORGANISMS 
IN SUBGINGIVAL PLAQUE SAMPLES AND ATHEROMATOUS PLAQUE 
SAMPLES. 
 
Site 1: SUBGINGIVAL PLAQUE 
    Site 2: ATHEROMATOUS PLAQUE 
 
Table 8 
THE COMPARATIVE PREVALENCE OF T.forsythia MICROORGANISMS 
IN SUBGINGIVAL PLAQUE SAMPLES AND ATHEROMATOUS PLAQUE 
SAMPLES. 
 
 
Site 1: SUBGINGIVAL PLAQUE 
    Site 2: ATHEROMATOUS PLAQUE 
 
 
Site 2  
Total Absent Present 
Site 1 
Absent 2 0 2 
Present 7 16 23 
Total 9 16 25 
% in both site 1and site2  64%  
P Value  0.008  
 Site 2  
Total Absent Present 
Site 1 Absent 5 0 5 
Present 6 14 20 
Total 11 14 25 
%   in both site 1 and site2  56%  
P value  0.031  
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Table 9 
THE COMPARATIVE PREVALENCE OF T.DENTICOLA 
MICROORGANISMS IN SUBGINGIVAL PLAQUE SAMPLES AND 
ATHEROMATOUS PLAQUE SAMPLES. 
 
 
 
Site 2  
Total Absent Present 
Site 1 
Absent 1 0 1 
Present 5 19 24 
Total 6 19 25 
  76%  
P value  0.016  
 
Site 1: SUBGINGIVAL PLAQUE 
Site 2: ATHEROMATOUS PLAQUE 
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Photograph No.17 Electrophoresis showing the  
amplified product of P.gingivalis. 
 
 
M-100 bp Ladder 
 
Lane 1, 2, 3, 4, 5, 6 – P.gingivalis 16S rDNA (404 bp)  
Lane 7 – Blank Control 
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Photograph No.18  Electrophoresis showing the  
amplified product of T.denticola. 
 
M-100 bp Ladder 
Lane 1, 2, 3, 4, 5, 6 – T.denticola 16S rDNA (316 bp)  
Lane 7 – Blank Control 
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Photograph No.19  Electrophoresis showing the  
amplified product of T.forsythia. 
 
M-100 bp Ladder 
Lane 1, 3, 4, 5, 6 – T.forsythia 16S rDNA (641 bp)  
Lane 7 – Blank Control 
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SEQUENCE OF PCR PRODUCT – INTERPRETATION 
 
SEQUENCE  ANALYSIS OF 16S rDNA GENE of P.GINGIVALIS 
 
The present study, the PCR positive amplicon of P.gingivalis positive sample 
of subgingival plaque and atheromatous plaque was purified and the nucleotide 
sequence was deduced by automated sequencer.  The sequence was blasted in the 
blast programme available in the NCBI web site and found that the sequences aligned 
with the P.gingivalis nucleotide sequences available in the GenBank. 
SEQUENCE OF ANALYSIS OF 16S rDNA Gene SPECIFIC FOR 
PORPHYROMONAS GINGIVALIS (FORWARD PRIMER) 
TGGTAGTCCACGCAGTAAACGATGATTACTAGGAGTTTGCGATATACCGTCAAGCTTCCA 
CAGCGAAAGCGTTAAGTAATCCACCTGGGGAGTACGCCGGCAACGGTGAAACTCAAAGGA 
ATTGACGGGGGCCCGCACAAGCGGAGGAACATGTGGTTTAATTCGATGATACGCGAGGAA 
CCTTACCCGGGATTGAAATGTAGATGACGGATGGTGAAAACCGTCTTCCCTTCGGGGCGT 
CTATGTAGGTGCTGCATGGTTGTCGTCAGCTCGTGCCGTGAGGTGTCGGCTTAAGTGCCA 
TAACGAGCGCAACCCACATCG 
Annexure 
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Reverse 
CCTTTCGGCCTTCTTCATTCACACGGCGTCGCTCCGTCAGACTTTCGTCCATTGCGGAAG 
ATTCTTAGCTGCTGCCTCCCGTAGGAGTTTGGGCCGTATCTCAGTCCCAATGTGTCCGTT 
CACCCTCTCAGGCCGGATACCCATCGTTGCCTTGGTGAGCCTTTACCTCACCAACCAGCT 
AATGGGACGCGGGCCCATCCTGAAGCGGACCGTAGCTCCTTTCCTCATTTACCTTTATGT 
AAA 
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SEQUENCE  ANALYSIS OF 16S rDNA GENE of T.forsythia 
 
The present study, the PCR positive amplicon of T.forsythia positive sample of 
subgingival plaque and atheromatous plaque was purified and the nucleotide sequence 
was deduced by automated sequencer.  The sequence was blasted in the blast 
programme available in the NCBI web site and found that the sequences aligned with 
the T.forsythia nucleotide sequences available in the GenBank. 
 
SEQUENCE OF  T.forsythia 
 
Forward 
GGGGTTCCGCATGGGGCTATTTGTTAAGATTTATTGGTTGCGGATGGGCATGCGTACATT 
AGGTAGTTGGTGAGGTACGGCTCACAAGCCATCGATGGTTAGGGGTTCTGAGAGGAAGGT 
CCCCCACACTGG 
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Reverse 
CATTCCGCCTACTTCATCTATACTCAAGACTACCAGTTTCAACGGCAATTTTA 
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SEQUENCE  ANALYSIS OF 16S rDNA GENE of T.denticola 
 
 
The present study, the PCR positive amplicon of T.denticola positive sample 
from subgingival plaque and atheromatous plaque was purified and the nucleotide 
sequence was deduced by automated sequencer.  The sequence was blasted in the 
blast programme available in the NCBI web site and found that the sequences aligned 
with the T.denticola nucleotide sequences available in the GenBank. 
SEQUENCE OF  Treponema denticola 
Forward 
ATGAGGAAGGAGCTACGGCTCCGCTTCAGGATGGGCCCGCGTCCCATTAGCTGGTTGGTG 
AGGTAAAGGCCCACCAAGGCAACGATGGGTATCCGGCCTGAGAGGGTGAACGGACACATT 
GGGACTGAGATACGGCCCAAACTCCTACGGGGAGGCAGCAGC 
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Reverse 
CCTACATAGACGCCCCGAAGGGAAGACGGTTTTCACCATCCGTCATCTACATTTCAATCC 
CGGGTAAGGTTCCTCGCGTATCATCGAATTAAACCACATGTTCCTCCGCTTGTGCGGGCC 
CCCGTCAATTCCTTTGAGTTTCACCGTTGCCGGCGTACTCCCCAGGTGGATTACTTAACG 
CTTTCGCTGTGGAAGCTTGACGGTATATCGCAAACTCCTAGTAATCATCGTTTACTGCGT 
GGACTACCAGGGTATCTAATCCTGTTTGATACCCACGCCTTCGTGCTTCAGTGTCAGTCG 
C 
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DISCUSSION 
Periodontitis is a chronic infectious disease characterized by inflammatory 
changes in the periodontal tissues. The disease occurs as a result of infection 
associated with a small number of predominately gram negative microorganisms. 
Atherosclerosis has been defined as a progressive disease process that causes 
focal thickening of large to medium sized muscular and large elastic arteries.(Beck 
JD et al 2000)8 Atherosclerosis is the most common cause of coronary artery disease 
(CAD) (Becker AE et al 2001)10. World Health Organisation statistics indicated that 
in 1993, cardiovascular diseases were responsible for 19% of deaths (10million) 
worldwide (World health report 1995)92. 
In recent years, an increasing number of epidemiological studies have 
indicated that periodontitis may increase the risk of cardiovascular events. (Beck JD 
et al 2001)7.   This effect may be due to the direct effect of periodontal pathogens or 
their product on endothelial cells via transient bacteraemia (Geerts SO et al 2002)31. 
In cell cultures, invasive P.gingivalis and fimbria stimulate endothelial cell activation, 
a necessary initial event in the development of atherogenesis (Takahashi Y et al 
2006)84. 
Higashi et al in 200843 reported that the periodontitis is associated with 
endothelial dysfunction in subjects without cardiovascular risk factors, as illustrated 
by a decrease in Nitrous Oxide bioavailability, and that systemic inflammation as a 
cause of endothelial dysfunction may lead to cardiovascular diseases. 
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A case control study showed that periodontitis is associated with endothelial 
dysfunction, and that 6 months after therapy, the benefits in oral health may be 
associated with improvement in endothelial function (Tonetti MS et al 2007)88. 
Experimental animal models (Apo E mice) demonstrated that P.gingivalis 
chronic inoculations increased lipid profiles,enhanced atheroma formation, and 
facilitated the calcification of atherosclerotic plaque (Li L et al 2002)54. 
De stefeno et al in 199323 based on 14 years of research on 9,760 individuals 
aged 25 to74 years reported an elevated risk of coronary disease in the group with 
periodontitis (25% higher). 
Beck et al in 19966 recorded that the periodontal status of 1,147 individuals 
undergoing a 20 year long observation. In the group with advanced periodontal 
disease, there was an increased risk of severe cardiac episodes and cerebral stroke (1.9 
and 2.8 times respectively) compared to the group without periodontitis. 
Finnish authors have attempted to evaluate the relationship between chronic 
tooth –related infections, expressed as the number of lost teeth, and coronary disease. 
They showed that the incidence of coronary disease in individuals who had lost less 
than half of their teeth is 10% higher, rising to two –fold higher in the group that had 
lost more than half of their dentition. The number of teeth lost proved to be a 
significant risk factor of coronary disease, but only in smokers. (Paunio K et al 
1993)69. It is difficult to evaluate the strength of association between periodontal and 
cardiovascular diseases, because those two conditions have several common risk 
factors (ScannapiecoFA et al 2003)78. 
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However, recent randomized controlled clinical trials conducted by D’Aiuto 
et al21 showed that intensive periodontitis therapy in otherwise generally healthy 
patients significantly reduces several inflammatory marker: IL6, cholesterol, and C-
reactive protein levels and systolic blood pressure. According to the Framingham risk 
scale, intensive treatment of periodontitis reduces the relative probability of 
developing cardiovascular disease by 1.5% to 2% (D’Aiuto F et al 2006)21. 
It has been hypothesized that gram negative bacteria can migrate from 
pathogenic dental plaque to the blood stream, passing through the inflammatory, 
damaged epithelial attachment. The epithelial lining of the periodontal pocket, which 
frequently becomes thin and ulcerated in the course of periodontitis, may then provide 
an entry point for bacteria of subgingival plaque, allowing access to the underlying 
tissues and, eventually to the vasculature. Spreading with the blood, the bacteria can 
affect inflammatory cells present in atherosclerotic plaque and stimulate a cascade of 
processes leading to atherosclerotic plaque instability (Erickson27, Herzberg M.A42, 
Haraszthy et al39). 
The present study does not unequivocally prove this theory, because bacteria 
were less frequent in atherosclerotic plaque than in dental plaque, and there was no 
distinct correlation between the amount of bacteria in subgingival plaque and 
coronary vessels. 
On the other hand, our data do not exclude the bacterial theory, because P. 
gingivalis, T.forsythia, and T.denticola were found in the material collected from 
cardiac vessels; these bacteria are intimately related to chronic periodontitis. 
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Several methods have been applied to analyze a microbial population of 
subgingival plaque. The conventional method has been culture techniques. Because 
most putative periodontopathogenic bacteria are anaerobic and have fastidious growth 
behaviour, the selective medium used and the processing time required for culturing 
particular organisms, as well as the transport medium for samples, could contribute to 
the discrepancy in data analyzed. Species level identification of isolates is laborious 
and time consuming. [Ali RW, et al 19943, Loesche WJ et al 199256] Immunological 
methods such as indirect immunofluorescence assay (IFA) or enzyme-linked 
immunosorbent assay (ELISA) require  
Sensitivity ranges among the organisms have been reported as additional 
disadvantages for immunological methods. [Melvin W. L et al 199460] The detection 
limit of whole chromosomal DNA probes is known to be about 104 cells whereas 
PCR can detect organisms of less than 100 cells.[Ashimoto A et al 19962]Hence PCR 
technique was opted for this study. 
PCR is carried out in discrete cycles and each cycle of amplification can, if 
100 % efficient doubles the amount of target DNA. The target DNA is exponentially 
amplified such that after n cycles, there is 2n times as much target DNA as was 
present initially. [Erlich HA et al 199128] The 16S rDNA PCR proved to be an 
accurate, relatively straightforward, and reproducible method for identification of 
P.gingivalis. T.denticola ,T.forsythia and A.actinomycetemcomitans. Similar methods 
have been used by other laboratories with a good success. [Ashimoto A et al 19962, 
Conrads G et al 199720.]  
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Traditionally, subgingival plaque samples have been taken with either a 
curette or paper point and some variations have been documented between and within 
these sampling methods. [Tanner AC et al 198686] Sampling by paper point is less 
invasive than by curette but may result in an underestimation of tightly adherent 
bacteria in subgingival sites. [Hartroth B et al 199940] Hence in this study, curettes 
were used for sample collection. 
In the present study, subgingival plaque samples and atheromatous plaque 
specimen were examined with the PCR technique using specific primers for 
periodontal pathogens. The DNA of atleast one of the target bacteria was detected in 
96% of the subgingival sample. The prevalence of P.gingivalis, 
T.denticola,T.forsythia was 92% ,80%, and 96% respectively. The sequence of 
periodontal bacterial DNA in the atheromatous plaques could be ascertained by DNA 
sequencing and they were compared with type strains sequences from the Gen Bank  
by blast to confirm their sequence homology. the prevalence of P.gingivalis, 
T.forsythia ,T.denticola was 64%, 56% and 76% respectively. The DNA of 
periodontal bacteria except A.actinomycetemcomitans was detected in both 
subgingival samples and atheromatous samples. In contrast to the study by Padilla C 
et al in 200667 who showed the presence of A.actinomycetem comitans in 
atheromatous plaques and the periodontal pockets of the same patients and also stated 
that, this could indicate a role for periodontal pathogenic bacteria in the 
atherosclerosis disease process.  
 
Almetti M et al in 20071 observed that, Bacterial DNA was detected in 31 out 
of 33 endarterectomy specimens. However, none of the samples tested positive for 
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DNA from periodontal pathogens. The presence of periodontal bacteria in 
atheromatous plaques was not confirmed by his investigation. But in contrast to this in 
this study in 16 of 25 cases, P.gingivalis was present in both subgingival samples and 
atheromatous plaque samples. T.denticola and T.forsythia were present in both 
subgingival samples and atheromatous samples in 19 and 14 cases respectively. The 
data of this study were consistent with those reported by Haraszthy et al39 ( PCR –
amplified 16S rDNA species –specific probes , 30% positive for T.forsythia,26% for 
P.gingivalis, 14% for P. Intermedia) Ishiara et al46 (PCR –amplified  16S rRNA, 
21.6% positive for P.gingivalis , 5.9%  for  T.forsythia) and ZHANG Yung–ming  
et al94 ( PCR-amplified 16S r DNA , 31%positive for T.forsythia,12%  for F. 
nucleatum,18% P.intermedia and  33%  for P.gingivalis. 
The most frequently identified bacteria were P.gingivalis and T.denticola. This 
data corroborates with the study by Maciej Zaremba et al 200758. 
The presence of periodontal bacteria DNA in coronary atheromatous plaque 
and subgingival plaque samples of the same patients was confirmed by this study and 
thus a correlation was established between putative bacteria contributing to 
atheromatous plaque and species associated with periodontal diseases. 
As a result of small number of patients included in this work, which is a major 
limitation of this study, it is not possible to obtain conclusive statistical results; 
nevertheless, the presence of P.gingivalis, T.denticola and T.forsythia in the 
periodontal samples and in the atheromatous plaques of the same patients, support the 
potential role of this periodontopathogenic bacterial species in some step of the 
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atherogenesis process or as a contributor of a different mechanism that worsens this 
disease.  However, if this association is casual, a deeper evaluation of periodontal 
diseases is necessary.  This work opens new insights regarding the potential risk of 
P.gingivalis, T.denticola and T.forsythia for atherosclerosis.  Further molecular 
studies are required for a better understanding of this association. 
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SUMMARY AND CONCLUSION 
The study was performed on twenty five individuals with atherosclerosis. 
Atheromatous Plaques were collected from the patients during endarterectomy and the 
subgingival plaque was collected from the same patients with clinical attachment 
level ≥  4mm. Total DNA isolation was done, the presence of 16S rDNA for 
P.gingivalis,T.denticola, T.forsythia and A.actinomycetemcomitans was determined 
using PCR technique.  The products were sequenced and they were compared with 
type strains from Gen Bank by blast to confirm their sequence homology.  
McNemar’s Test was used for statistical analysis. 
The DNA of atleast one of the target bacteria was detected in 96% of 
thesubgingival plaque samples.  The prevalence of P.gingivalis, T.denticola, and 
T.forsythia was 92%, 80% and 96% respectively. The prevalence of P.gingivalis, 
T.forsythia, and T.denticola in atheromatous plaque samples was 64%, 56% and 76% 
respectively. The DNA of periodontal bacteria except A.actinomycetemcomitans was 
detected in both subgingival samples and atheromatous samples. In 16 of 25 cases, 
P.gingivalis was present in both subgingival samples and atheromatous plaque 
samples at P value of 0.008. In 19 cases, T.denticola was present in both subgingival 
samples and atheromatous plaque samples at P value of 0.031 and T.forsythia were 
present in both subgingival and atheromatous plaque samples in 14 cases at P value of 
0.016.  
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The presence of periodontal bacteria DNA in coronary atheromatous plaque 
and subgingival plaque samples of the same patients was confirmed by this study and 
thus a correlation was established between putative bacteria contributing to 
atheromatous plaque and species associated with periodontal diseases. The link found 
in this study supports the concept that there may be a true link between atherogenesis 
and periodontitis. 
It is well known that bactermia can occur after procedures such as extraction, 
root canal treatment, and scaling.  However, research results suggest that anaerobic 
bacteremia may also occur as a result of toothbrushing and probing of periodontal 
pockets. (Heimdahl A et al 199041, Roberts GJ 199972, Roberts GJ et al 199273) 
Nevertheless, this bacteremia does not pose any threat to a healthy host because, 
according to research by Pallash and Slots 199668, it is eliminated by the host’s 
immune system within a few minutes.  Our results support the possibility that bacteria 
associated with periodontitis can permeate into coronary vessels.  Therefore, it seems 
important to limit this process.  To achieve this goal, systematic dental-plaque 
elimination is crucial, as well as the elimination of retention points favouring its 
accumulation.  The reduction of bacteria present in supra- and subgingival plaque 
may be an important prophylaxis for periodontal and coronary diseases.  
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PROFORMA 
MICROBIOLOGICAL ANALYSIS OF PERIODONTAL POCKET AND    
CORANARY ATHEROMATOUS PLAQUE IN ATHEROSCLEROTIC 
PATIENTS 
 
NAME    OP.NO   DATE  
   
 
AGE / SEX    ADDRESS  
 
 
CHIEF COMPLAINTS (CVS) 
 
History of presenting illness  : 
Past Medical History   : 
If under Medication   : 
Duration of Medication  :  
H/O Professional cleaning  :  Yes / No                                                                   
H/O Diabetes    :  Yes / No                                                                   
H/O Bleeding Disorder  :  Yes /No 
H/O Smoking    :  Yes /No  
General Examination  
BP : 
Pulse  : 
Respiratory rate : 
Weight : 
Annexure 
 
78 
 
Height     : 
BSA     : 
Past Dental History   : 
Local Examination   : 
No. of Teeth Present   : 
Extracted Teeth   : 
(Reason for Extraction  : 
 When Extracted) 
Decayed / Filled Teeth  : 
 
Investigations    
Blood     : 
Total Serum Cholesterol  : 
Total triglycerides   : 
High density lipoprotein  : 
 
Low density lipoprotein is calculated using the formula  
 
Low Density Lipoprotein  =  Total Serum Cholesterol –   
                                                 (Triglycerides / 2.2 + High Density  
Lipoprotein)  in mgs/dl 
• SGOT 
• SGPT 
• Alkaline Phosphatase 
• CPK 
• CPK – MB 
• Trop 
• Fasting blood glucose level 
• Serum creatinine 
• Haeomoglobin 
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• P.C.V. 
• Platelete Count 
• RBC Count 
• WBC Count 
• Neutrophils 
• Lymphocytes 
• Eosinophils 
• E.S.R. 
• B.T. 
• C.T. 
• P.T. 
• INR 
• A.P.T.T 
 
CLINICAL PARAMETERS: 
PLAQUE INDEX:  (Silness & Loe 1964)  
 
 
 
Plaque Index Score:___________ 
Inference:  (Excellent/ Good / Fair / Poor) 
PROBING POCKET DEPTH [PPD], CLINICAL ATTACHMENT 
LEVEL [CAL]  
(In mm): 
Maxillary 
BUCCAL 
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CAL                 
PPD                 
 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28
PPD                                     
CAL                 
PALATAL 
Mandibular 
BUCCAL 
CAL                 
PPD                 
 48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
PPD                                     
CAL                 
LINGUAL 
 
PRESENCE OF 16S rDNA: 
Presence of 16S 
rDNA P.gingivalis T.denticola T.forsythia 
A.actinomycete
mcomitans 
Subgingivalplaque     
Atheromatous 
plaque 
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INFORMED CONSENT FORM-ENGLISH 
Study Title: 
Microbiological analysis of periodontal pocket and coronary 
atheromatous plaque in atherosclerotic patients 
Date:                                           O.P. No: 
Name:       Code No: 
Address:      Age/Sex: 
       Tel. No: 
I,  age yrs, exercising my free power of choice, hereby give my consent to be 
included as a participant in the clinical study “Microbiological analysis of 
periodontal pocket and coronary atheromatous plaque in 
atherosclerotic patients  
I agree to the following: 
I have been informed to my satisfaction about the purpose of the study, and 
nature of the study. 
I understand that I should undergo endarterectomy procedure as a part of  
treatment for  my condition in the heart.The atheromatous plaque sample taken 
during the procedure will be used for study purpose and serves the purpose of 
treatment and will not affect the treatment. 
I understand that the investigations will also require oral plaque sample in 
required amounts.  
I agree to co-operate fully and participate in the study. 
I hereby give permission to use the records for study. I am told that study 
doctor and study institution will keep my identity confidential. 
 
 
Signature of the        Signature of the 
Investigator        Participant  
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MuhŒ¢Á x¥òjš got« 
MuhŒ¢Á jiy¥ò 
‘mÂnuh°»èbuho¡ nehahëfë‹ g‰gly« k‰W« fnuhdç mÂnuhkhl° gly« g‰¿a 
E©Qæçæaš MŒÎ’ 
 
ehŸ      òw nehahë v© 
bga®      F¿p£bl© 
Kftç      taJ / ghèd« 
      bjhiyngÁ v© 
 eh‹ .........................................................  taJ ....................... v‹Dila RaãidÎlD« 
KG RjªÂu¤JlD« ‘‘mÂnuh°»èbuho¡ nehahëfë‹ g‰gly« k‰W« fnuhdç mÂnuhkhl° 
gly« g‰¿a E©Qæçæaš MŒÎ’ v‹D« Ïªj kU¤Jt MuhŒ¢Áæš v‹id nr®¤J¡ bfhŸs 
r«kÂ¡»nw‹. 
Ã‹ tUtd‰¿‰F eh‹ r«kÂ¡»nw‹:- 
MuhŒ¢Áæ‹ neh¡f« k‰W« j‹ik F¿¤J vd¡F KG ÂU¥Âaë¡F«go és¡f¥g£lJ. 
vdJ ÏUja¤Â‹ ãiyik F¿¤J, Á»¢iræ‹ xU gFÂahf v‹lh®blu¡lä brŒa¥gl nt©L« v‹gijÍ« 
vL¡f¥gL« mÂnuhkhl° gly« MŒÎ¡F¥ ga‹gL¤j¥gL« v‹gijÍ« ÏJ Á»¢iria v›éj¤ÂY« ghÂ¡fhJ 
v‹gijÍ« eh‹ cz®»nw‹. 
gçnrhjid brŒtj‰fhf njitahd msÎ g‰gly« vL¡f¥gl nt©L« v‹gij eh‹ cz®»nw‹. 
MŒÎ¡F v‹ KG x¤JiH¥igÍ« më¥ng‹ vd cWÂ TW»nw‹. 
V‹Dil kU¤Jt¤ juÎfis MŒÎ¡F¥ ga‹gL¤Â¡ bfhŸs mDkÂ më¡»nw‹.  vdJ Ra étu§fis 
kU¤JtU« MŒtfK« ÏufÁakhf it¤ÂU¥gh®fŸ vd m¿»nw‹. 
 
 
MuhŒ¢Áahsç‹    be¿ahsç‹   g§F bgWgtç‹ 
       ifbah¥g«      ifbah¥g«          ifbah¥g« 
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MASTER CHART 
TABLE  - 1  General  Characteristics and Presence of Micro Organisms in Sub Gingival Plaque 
 
S.N Age Sex Site PPD CAL P.gingivalis A.actinomycetemcomitans T.denticola T.forsythia
1 58 male 16 mesial 6 6 + - - +
2 61 male 36 mesial 5 5 + - + -
3 54 male 16 mesial 6 6 + - + + 
4 62 female 46 mesial 7 7 + - + +
5 51 male 36 mesial 7 7 + - + +
6 61 male 46 distal 6 6 + - + +
7 58 female 36 mesial 7 7 + - + +
8 68 male 36 distal 7 7 + - + +
9 43 male 46 distal 6 7 + - + +
10 59 male 36 distal 5 5 + - + -
11 57 male 46 distal 7 7 + - + +
12 41 male 46 distal 7 7 + - + +
13 60 female 36 distal 7 7 + - + +
14 53 male 46 distal 6 6 + - + +
15 63 male 45distal 6 6 + - + +
16 55 female 26 mesial 6 6 + - + +
17 66 male 36 distal 7 7 + - + -
18 60 male 17 mesial 5 5 - - + +
19 56 male 27 distal 5 5 + - + +
20 48 male 37 distal 5 5 + - + -
21 58 male 46 distal 5 5 + - + +
22 70 female 36 distal 6 6 + - + +
23 61 male 36 distal 6 6 + - + +
24 60 male 46 mesial 5 5 + - + +
25 47 male 36 mesial 4 4 - - + -
 
 Present (+)    Absent (-) 
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MASTER CHART 
TABLE  - 2  General  Characteristics and Presence of Micro Organisms in Atheromatous Plaque 
S.NO Age Sex Site CPK (U/L) 
CPK-MB 
(U/L) 
LDH 
(U/L) P.gingivalis 
A.actinomycete
mcomitans T.denticola T.forsythia 
1 58 male LIMA 396 140 410 - - - -
2 61 male LIMA-LAD 234 306 22.7 - - + -
3 54 male LIMA-LAD 604 41 705 - - - -
4 62 female LIMA-LAD 485 43 638 + - + +
5 51 male LIMA-LAD 305 42 509 + - + +
6 61 male LAD 419 36 430 - - + +
7 58 female LIMA-LAD 816 98 682 + - + +
8 68 male LIMA-LAD 286 39 572 + - + +
9 43 male LIMA-LAD 284 34 514 + - + +
10 59 male LIMA-LAD 536 50 517 - - - -
11 57 male LIMA-LAD 306 39 503 + - + +
12 41 female LIMA-LAD 422 39 560 + - + - 
13 60 male RCA 108 32 419 + - + +
14 53 male LIMA-LAD 393 43 812 + - + +
15 63 male LIMA-LAD 210 30 453 - - - -
16 55 female RCA 781 80 797 + - + -
17 66 male LIMA 468 40 615 + - + -
18 60 male LIMA 688 97 691 - - + +
19 56 male LIMA 456 84 687 - - - -
20 48 male LIMA 637 74 667 + - + -
21 58 male LIMA-LAD 498 66 517 + - + +
22 70 female LIMA-LAD 885 103 1020 + - + +
23 61 male LIMA-LAD 296 35 561 + - + +
24 60 male RCA 74 21 588 + - + +
25 47 male LIMA-LAD 310 39 575 - - - -
 
 Present (+)    Absent (-) 
